"CPT Copyright 2016 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.""

Featured Post

2018 New CPT codes

00731  Anesthesia for upper gastrointestinal endoscopic procedures, endoscope introduced proximal to duodenum; not otherwise specified ...

2011 PQRS / PQRI Gastroenterology Measure Specifications

2011 Physician Quality Reporting System (“Physician Quality Reporting,” formerly known as Physician Quality Reporting Initiative or PQRI). Each measure is assigned a unique number. Measure numbers for 2011 Physician Quality Reporting represent a continuation in numbering from the 2010 measures. For 2010 PQRI measures that are continuing forward in the 2011 Physician Quality Reporting System, measure specifications have been updated. In addition to the measure specifications manual, please refer to the “2011 Physician Quality Reporting System Implementation Guide” for additional information essential in assisting eligible professionals’ understanding and submission of measures.

Measures pertaining to Gastroenterology for the 2011 PQRS program and the Reporting options (C - Measure Reporting via Claims / R - Measure Reporting via Registry) are listed below

Measure 84 - Hepatitis C: Ribonucleic Acid (RNA) Testing Before Initiating Treatment. [C, R]

Measure 85 - Hepatitis C: HCV Genotype Testing Prior to Treatment. [C, R]

Measure 86 - Hepatitis C: Antiviral Treatment Prescribed. [C, R]

Measure 87 - Hepatitis C: HCV Ribonucleic Acid (RNA) Testing at Week 12 of Treatment. [C, R]

Measure 89 - Hepatitis C: Counseling Regarding Risk of Alcohol Consumption. [C, R]

Measure 90 - Hepatitis C: Counseling Regarding Use of Contraception Prior to Antiviral Therapy. [C, R]

Measure 113 - Preventive Care and Screening: CRC screening. [C, R]

Measure 124 - Health Information Technology (HIT): Adoption/Use of Electronic Health Records (EHR). [C, R]

Measure 183 - Hepatitis C: Hepatitis A Vaccination in Patients with HCV. [C, R]

Measure 184 - Hepatitis C: Hepatitis B Vaccination in Patients with HCV. [C, R]

Measure 185 - Endoscopy & Polyp Surveillance: Colonoscopy Interval for Patients with a History of Adenomatous Polyps – Avoidance of Inappropriate Use. [C, R]

For detailed information on 2011 Measure specifications and Implementation guide please refer http://www.cms.gov/PQRI/15_MeasuresCodes.asp#TopOfPage

Popular Posts